Received Aug 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Z002991 | OT / RA |
No Additional AE; Caller reported PROQUAD was administered to an adult. No other information provided. No Additional AE/PQC reported.; This spontaneous report was received from a Nurse and refers to an adult patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 30-Jul-2025, the (adult) patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), 0.5 mL, lot #Z002991, expiration date: 14-Jul-2026, administered by intramuscular route in the right arm as prophylaxis (Product administered to patient of inappropriate age). The vaccine was reconstituted with sterile diluent (no details provided). No other information provided. No additional adverse events. At the reporting time, the outcome of the events was unknown. The action taken with the suspect products was not reported, but established as not applicable.
Sterile diluent